SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Expert advice for new stargazers: How to begin your amateur astronomy journey - 2Flu activity rises sharply across US with 7.5 million cases, CDC data shows
- 3Scientists sent a menstrual cup to space. This is how it went
- 4China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
- 5Jennifer Lawrence and Josh Hutcherson to reprise their roles for new 'Hunger Games' movie 'Sunrise on the Reaping'
- Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- Top Breakfast Food: What's Your Morning Enjoyment?
- Which One Energizes You the Most These Tech Developments
- Support Your Wellness: 20-Minute Home Exercises That Work
- The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing
- Looter indicted after pretending to be emergency worker at Dimona rocket crash site
- Astronomers detect black hole blasting winds at incredible speeds
- New materials, old physics – the science behind how your winter jacket keeps you warm
- Germany records first wolf bite on human since repopulation
